Authors:
Yim, DS
Park, SK
Yoo, KY
Yoon, KS
Chung, HH
Kang, HJ
Ahn, SH
Noh, DY
Choe, KJ
Jang, IJ
Shin, SG
Strickland, PT
Hirvonen, A
Kang, DH
Citation: Ds. Yim et al., Relationship between the Val(158)Met polymorphism of catechol O-methyl transferase and breast cancer, PHARMACOGEN, 11(4), 2001, pp. 279-286
Authors:
Kang, JH
Kim, SJ
Noh, DY
Choe, KJ
Lee, ES
Kang, HS
Citation: Jh. Kang et al., The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer, J MOL MED-J, 79(11), 2001, pp. 648-655
Authors:
Kim, HK
Park, IA
Heo, DS
Noh, DY
Choe, KJ
Bang, YJ
Kim, NK
Citation: Hk. Kim et al., Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer, EUR J SUR O, 27(5), 2001, pp. 464-471
Authors:
Kim, TS
Moon, WK
Lee, DS
Chung, JK
Lee, MC
Youn, YK
Oh, SK
Choe, KJ
Noh, DY
Citation: Ts. Kim et al., Fluorodeoxyglucose positron emission tomography for detection of recurrentor metastatic breast cancer, WORLD J SUR, 25(7), 2001, pp. 829-834
Authors:
Kang, JH
Kim, SJ
Noh, DY
Park, IA
Choe, KJ
Yoo, OJ
Kang, HS
Citation: Jh. Kang et al., Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: Correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma, LAB INV, 81(4), 2001, pp. 573-579
Authors:
Park, SK
Yoo, KY
Lee, SJ
Kim, SU
Ahn, SE
Noh, DY
Choe, KJ
Strickland, PT
Hirvonen, A
Kang, DH
Citation: Sk. Park et al., Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk, PHARMACOGEN, 10(4), 2000, pp. 301-309
Authors:
Kang, HS
Youn, YK
Oh, SK
Choe, KJ
Noh, DY
Citation: Hs. Kang et al., Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer, BREAST CANC, 63(1), 2000, pp. 81-87
Authors:
Bang, SM
Heo, DS
Lee, KH
Byun, JH
Chang, HM
Noh, DY
Choe, KJ
Bang, YJ
Kim, SR
Kim, NK
Citation: Sm. Bang et al., Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillarylymph node positive breast carcinoma - Results of a randomized controlled trial, CANCER, 89(12), 2000, pp. 2521-2526
Authors:
Park, YJ
Park, KJ
Park, JG
Lee, KU
Choe, KJ
Kim, JP
Citation: Yj. Park et al., Prognostic factors in 2230 Korean colorectal cancer patients: Analysis of consecutively operated cases, WORLD J SUR, 23(7), 1999, pp. 721-726
Authors:
Park, YJ
Youk, EG
Choi, HS
Han, SU
Park, KJ
Lee, KU
Choe, KJ
Park, JG
Citation: Yj. Park et al., Experience of 1446 rectal cancer patients in Korea and analysis of prognostic factors, INT J COL R, 14(2), 1999, pp. 101-106